Dr. Sambol is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 Plainsboro Rd
Ste 400
Plainsboro, NJ 08536Phone+1 609-936-9100Fax+1 609-936-9700
Summary
- Dr. Elliot Sambol is a vascular surgeon in Plainsboro, NJ and is affiliated with Penn Medicine Princeton Medical Center. He received his medical degree from Rutgers New Jersey Medical School and has been in practice 17 years. He is experienced in peripheral vascular disease, varicose veins, chronic venous insufficiency , carotid disease, and aortic surgery.
Education & Training
- New York Presbyterian Hospital (Columbia and Cornell Campus)Fellowship, Vascular Surgery - Independent, 2007 - 2009
- NYU Grossman School of MedicineResidency, Surgery, 2000 - 2007
- Rutgers New Jersey Medical SchoolClass of 2000
- University of PennsylvaniaBA, Biological Basis of Behavior, Cum Laude, 1992 - 1996
Certifications & Licensure
- NJ State Medical License 2009 - 2025
- NY State Medical License 2002 - 2010
- American Board of Surgery Surgery
- American Board of Surgery Vascular Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Acumen nEHR, Health IT Services Group, 2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 183 citationsGene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated li...Samuel Singer, Nicholas D. Socci, Grazia Ambrosini, Elliot B. Sambol, Penelope DeCarolis
Cancer Research. 2007-07-15 - 18 citationsCarotid angioplasty and stenting, success relies on appropriate patient selectionMikel Sadek, Robert L. Hynecek, Elliot B. Sambol, Habib Ur-Rehman, K. Craig Kent
Journal of Vascular Surgery. 2008-05-01 - 131 citationsMouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.Grazia Ambrosini, Elliot B. Sambol, Daisy Carvajal, Lyubomir T. Vassilev, Samuel Singer
Oncogene. 2007-05-24
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: